Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA
Keywords: Non-Hodgkin's lymphoma (NHL); Interim monitoring; Minimal residual disease (MRD); Surveillance monitoring; Computed tomography (CT); Positron emission tomography (PET); Circulating tumor DNA (ctDNA);